CD80 and neuropathy: We found that neither neuropathy nor diabetes developed by 30 weeks of age in NOD-B7-2KO-H-2h4 mice after anti-B7-1 treatment, in contrast to NOD-B7-2KO mice which developed both diseases with 80–100% penetrance by 15-20 weeks of age (Fig. 5A).